Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FCY6P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,185
Award facts
- Contract value 100% obligated
- $29,185.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $29,185.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This is a non-set-aside award with an ultimate completion date of January 30, 2026. The product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. Vyndamax (tafamidis) is a disease-modifying therapy used to treat transthyretin (ATTR) amyloidosis, a rare but serious progressive disease, and its procurement through the DLA Medical Supply Chain supports the pharmaceutical needs of military treatment facilities and the Defense Health Agency.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s (doing business as AmerisourceBergen) substantial Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00 and extending through December 31, 2031, serves as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to military healthcare programs worldwide. AmerisourceBergen's capability to fulfill this specialized pharmaceutical requirement demonstrates its role as a critical vendor in the federal medical procurement ecosystem, serving federal healthcare systems on a fully competitive basis.
Quick answers
Who was awarded contract SPE2DR26FCY6P?
SPE2DR26FCY6P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FCY6P worth?
The government has obligated $29,185 on SPE2DR26FCY6P.
Is contract SPE2DR26FCY6P an order under another contract?
Yes. SPE2DR26FCY6P is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY6P competed?
The extent of competition for SPE2DR26FCY6P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award